Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Large-Scale Discovery of Enhancers from Human Heart Tissue

ABSTRACT: Large-Scale Discovery of Enhancers from Human Heart Tissue

PROVIDER: PRJNA147085 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR350618.fastq.gz	Fastqsanger.gz
	SRR350619.fastq.gz	Fastqsanger.gz
	SRR350620.fastq.gz	Fastqsanger.gz
	SRR350621.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Large-Scale Discovery of Enhancers from Human Heart Tissue

Project description:Development and function of the human heart depend on the dynamic control of tissue-specific gene expression by distant-acting transcriptional enhancers. While large numbers of heart enhancers have been identified using the mouse as a model system, many of these regulatory sequences are poorly conserved in the human genome. To generate an accurate genome-wide map of human heart enhancers, we used an epigenomic enhancer discovery approach and identified ~6,200 candidate enhancer sequences directly from fetal and adult human heart tissue. Consistent with their predicted function, these elements were markedly enriched near genes implicated in heart development, function and disease. To further validate their in vivo enhancer activity, we tested 65 of these human sequences in a transgenic mouse enhancer assay and observed that 43 (66%) drove reproducible reporter gene expression in the heart. These results support the discovery of a genome-wide set of non-coding sequences highly enriched in human heart enhancers which is likely to facilitate down-stream studies of the role of enhancers in development and pathological conditions of the heart. Examination of AcCBP/p300 binding in human adult heart, human fetal (16wk) heart and mouse postnatal day 2 heart

2011-12-04 | E-GEOD-32587 | biostudies-arrayexpress

Large-Scale Discovery of Enhancers from Human Heart Tissue

2011-12-04 | GSE32587 | GEO

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

| PRJNA1057933 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [DNAseq]

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [DNAseq]

| PRJNA1057941 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [DNaseI-seq]

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [DNaseI-seq]

| PRJNA1057940 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [CUT&RUN]

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [CUT&RUN]

| PRJNA1057938 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [RNA-seq]

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors [RNA-seq]

| PRJNA1057939 | ENA

Large-scale discovery of enhancers from human heart tissue.

Project description:Development and function of the human heart depend on the dynamic control of tissue-specific gene expression by distant-acting transcriptional enhancers. To generate an accurate genome-wide map of human heart enhancers, we used an epigenomic enhancer discovery approach and identified ?6,200 candidate enhancer sequences directly from fetal and adult human heart tissue. Consistent with their predicted function, these elements were markedly enriched near genes implicated in heart development, function and disease. To further validate their in vivo enhancer activity, we tested 65 of these human sequences in a transgenic mouse enhancer assay and observed that 43 (66%) drove reproducible reporter gene expression in the heart. These results support the discovery of a genome-wide set of noncoding sequences highly enriched in human heart enhancers that is likely to facilitate downstream studies of the role of enhancers in development and pathological conditions of the heart.

| S-EPMC3246570 | biostudies-literature

ChIP-seq Identification of Weakly Conserved Heart Enhancers

Project description:Accurate control of tissue-specific gene expression plays a pivotal role in heart development. However, few cardiac transcriptional enhancers have thus far been identified. Extreme non-coding sequence conservation successfully predicts enhancers active in many tissues, but fails to identify substantial numbers of enhancers active in the heart. We used ChIP-seq with the enhancer-associated protein p300 from mouse embryonic heart tissue to identify over three thousand candidate heart enhancers genome-wide. In contrast to other studied tissues at this time-point, most candidate heart enhancers are not deeply conserved in vertebrate evolution. Nevertheless, the testing of 130 candidate regions in a transgenic mouse assay revealed that most of them reproducibly function as enhancers active in the heart, irrespective of their degree of evolutionary constraint. These results provide evidence for tissue-dependent differences in evolutionary constraint of enhancers acting through the transcriptional co-activator p300 at this time-point, and identify a large population of poorly conserved heart enhancers. Examination of p300 binding in embryonic stage 11.5 mouse heart and midbrain

2010-08-22 | E-GEOD-22549 | biostudies-arrayexpress

Large-scale discovery proteomics - Nitrospira moscoviensis

Project description:A large-scale discovery proteomics experiment was performed on biomass of Nitrospira moscoviensis (Lab head, Dr. Sebastian Lücker, RU, NL). The soluble protein fraction was analysed following high pH reverse-phase peptide fractionation. The insoluble membrane fraction was solubilised by an optimised protocol and analysed following cleavage using different proteolytic enzymes to maximise proteome coverage.

2021-07-22 | PXD019583 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data